Novel Pyrimidines as Antitubercular Agents

Mycobacterium tuberculosis infection is responsible for a global pandemic. New drugs are needed that do not show cross-resistance with the existing front-line therapeutics. A triazine antitubercular hit led to the design of a related pyrimidine family. The synthesis of a focused series of these anal...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Inoyama, Daigo, Paget, Steven D., Russo, Riccardo, Kandasamy, Srinivasan, Kumar, Pradeep, Singleton, Eric, Occi, James, Tuckman, Margareta, Zimmerman, Matthew D., Ho, Hsin Pin, Perryman, Alexander L., Dartois, Véronique, Connell, Nancy, Freundlich, Joel S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2018
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5826157/
https://ncbi.nlm.nih.gov/pubmed/29311070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02063-17
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia